Company overview
AGI Glassplant manufactures engineered glass systems for chemical processing in pharmaceutical, chemical, and academic industries, scaling from laboratory to pilot plant and manufacturing levels. They specialize in custom solutions like filter reactors, acid purification systems, and pilot reactor controllers for reaction, filtration, and temperature control. With 70+ years of experience rooted in Japan, they offer global reach through subsidiaries in the USA, UK, Switzerland, and India.
Agi Glassplant is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include glass reactor, pilot plant glassware, pharma chemical processing, filter reactor, acid purification system.
Products and technologies associated with Agi Glassplant include Purification — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.agi-glassplant.com
- Markets served
- United States & Americas
- Keywords
- glass reactor, pilot plant glassware, pharma chemical processing, filter reactor, acid purification system
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What scales of glass systems does AGI Glassplant offer for pharma applications?
- AGI Glassplant provides engineered glassware from laboratory scale to pilot plant and manufacturing scale for chemical processing in pharmaceuticals.
- What custom capabilities does AGI Glassplant have for R&D?
- They specialize in custom systems for unique applications like acid purification, recycling, filter reactors, and optimizations such as ring baffles for superior temperature control.
- What are AGI Glassplant's global manufacturing and service locations?
- Rooted in Japan, they have subsidiaries and manufacturing sites in the USA, UK, Switzerland, and India for worldwide support.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
